Aurora Cannabis Total Assets 2017-2019 | ACB

Aurora Cannabis total assets from 2017 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Aurora Cannabis Annual Total Assets
(Millions of US $)
2019 $4,156
2018 $1,505
2017 $243
2016 $0
Aurora Cannabis Quarterly Total Assets
(Millions of US $)
Q4 2019 $4,156
Q3 2019 $4,175
Q2 2018 $3,687
Q1 2018 $3,793
Q4 2018 $1,505
Q3 2018 $1,322
Q2 2017 $576
Q1 2017 $278
Q4 2017 $243
Q3 2017 $0
Q2 2016 $0
Q1 2016 $0
Q4 2016 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.611B $0.215B
Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $144.323B 20.26
Abbott Laboratories (ABT) United States $141.074B 26.52
Stryker (SYK) United States $79.557B 27.51
Boston Scientific (BSX) United States $52.891B 25.66
Baxter (BAX) United States $44.520B 27.00
EssilorLuxottica Societe Anonyme (ESLOY) France $32.321B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.767B 17.77
Coloplast (CLPBY) Denmark $25.229B 40.28
Lonza Group Ag (LZAGY) Switzerland $24.768B 0.00
Terumo (TRUMY) Japan $23.431B 29.24
Smith & Nephew SNATS (SNN) United Kingdom $20.446B 0.00
ResMed (RMD) United States $18.578B 35.40
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $9.880B 52.96
Insulet (PODD) United States $9.176B 543.75
Perrigo (PRGO) Ireland $7.218B 13.30
Hill-Rom Holdings (HRC) United States $6.641B 19.80
Canopy Growth (CGC) Canada $6.561B 0.00
Haemonetics (HAE) United States $6.400B 48.30
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.322B 27.49
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.590B 0.00
Neogen (NEOG) United States $3.348B 56.02
NuVasive (NUVA) United States $3.295B 26.27
ICU Medical (ICUI) United States $3.139B 20.36
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.427B 0.00
Quidel (QDEL) United States $2.414B 23.97
Agios Pharmaceuticals (AGIO) United States $1.901B 0.00
National Vision Holdings (EYE) United States $1.871B 40.39
Cardiovascular Systems (CSII) United States $1.582B 0.00
Aphria (APHA) $1.099B 0.00
VAREX IMAGING (VREX) United States $1.093B 25.19
AtriCure (ATRC) United States $0.999B 0.00
Phibro Animal Health (PAHC) United States $0.870B 14.15
Eagle Pharmaceuticals (EGRX) United States $0.830B 21.16
NanoString Technologies (NSTG) United States $0.769B 0.00
PetIQ (PETQ) United States $0.746B 17.62
Omeros (OMER) United States $0.734B 0.00
Lantheus Holdings (LNTH) United States $0.731B 19.21
LeMaitre Vascular (LMAT) United States $0.643B 38.13
Cerus (CERS) United States $0.603B 0.00
Surmodics (SRDX) United States $0.581B 110.51
Quanterix (QTRX) United States $0.554B 0.00
MacroGenics (MGNX) United States $0.550B 0.00
TG Therapeutics (TGTX) United States $0.494B 0.00
OraSure Technologies (OSUR) United States $0.481B 22.27
Meridian Bioscience (VIVO) United States $0.404B 12.60
Owens & Minor (OMI) United States $0.392B 11.74
Zynex (ZYXI) United States $0.374B 39.69
Utah Medical Products (UTMD) United States $0.342B 25.03
BioLife Solutions (BLFS) United States $0.329B 101.19
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.308B 0.00
United Health Products (UEEC) United States $0.240B 0.00
Bovie Medical (APYX) United States $0.230B 0.00
Vapotherm (VAPO) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.153B 0.00
Cytosorbents (CTSO) United States $0.143B 0.00
Female Health (VERU) United States $0.135B 0.00
Fonar (FONR) United States $0.127B 8.94
InfuSystems Holdings (INFU) United States $0.126B 0.00
Chembio Diagnostics (CEMI) United States $0.098B 0.00
Chimerix (CMRX) United States $0.095B 0.00
United-Guardian (UG) United States $0.086B 20.43
Nephros (NEPH) United States $0.074B 0.00
MTech Acquisition (KERN) United States $0.060B 0.00
MRI Interventions (MRIC) United States $0.056B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Surface Oncology (SURF) United States $0.035B 0.00
Senestech (SNES) United States $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.021B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00